Author Archives: Admin

Congressional votes for last week of July

WASHINGTON, July 31 — Here’s a look at how area members of Congress voted over the previous week.

House Vote 1: NEEDLE DISTRIBUTION PROGRAMS:

The House rejected an amendment sponsored by Rep. Mark Souder, R-Ind., to the Departments of Labor, Health and Human Services, Education and Related Agencies Appropriations Act (H.R. 3293), that would have barred funding for programs to distribute needles for injecting drugs.

Proponents said the funds could instead be used for drug treatment and said needle distribution would erase accountability for dangerous behavior by allowing easier access to drug-related paraphernalia. Opponents said "there’s overwhelming evidence that we can help stop the spread of AIDS by allowing needle exchange programs."
The vote, on July 24, was 211 yeas to 218 nays. YEAS: Rep. Dan Boren D-OK (2nd), Rep. Tom Cole R-OK (4th), Rep. Mary Fallin R-OK (5th), Rep. Frank D. Lucas R-OK (3rd), Rep. John Sullivan R-OK (1st)

2: PLANNED PARENTHOOD PROGRAMS: The House rejected an amendment sponsored by Rep. Mike Pence, R-Ind., to the Departments of Labor, Health and Human Services, Education and Related Agencies Appropriations Act (H.R. 3293) that would have barred funding for Planned Parenthood under the bill.

Proponents said "it’s morally wrong to use the taxpayer dollars of millions of pro-life Americans to fund abortion providers" and that providing the funding would allow the group to free up resources to engage in abortion practices against the will of the people.

Opponents said the amendment would have no impact on abortions and would limit important health care access for low-income and uninsured patients. The vote, on July 24, was 183 yeas to 247 nays. YEAS: Rep. Dan Boren D-OK (2nd), Rep. Tom Cole R-OK (4th), Rep. Mary Fallin R-OK (5th), Rep. Frank D. Lucas R-OK (3rd), Rep. John Sullivan R-OK (1st)

House Vote 3: LABOR, HEALTH, AND EDUCATION FUNDING: The House approved the Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R. 3293), sponsored by Rep. David Obey, D-Wis.

Proponents said the bill was a fiscally responsible effort to improve various health and education programs that would accurately represent the values of the country. Opponents criticized what they called ‘excessive spending’ in the bill and said it set "the foundation for the implementation of health care reform [which could result in] the rationing of health care."

The vote, on July 24, was 264 yeas to 153 nays. YEAS: Rep. Dan Boren D-OK (2nd) NAYS: Rep. Tom Cole R-OK (4th), Rep. Mary Fallin R-OK (5th), Rep. Frank D. Lucas R-OK (3rd), Rep. John Sullivan R-OK (1st)

House Vote 4: WACO MAMMOTH NATIONAL MONUMENT: The House approved the Waco Mammoth National Monument Establishment Act (H.R. 1376), sponsored by Rep. Chet Edwards, D-Texas. Proponents said the site was a national treasure that preserved the remains of mammoths and other species and offered "a unique find of national and international importance" for scientists and the general public. Opponents said the bill lacked "language protecting the property rights on lands adjacent to the monument."

The vote, on July 27, was 308 yeas to 74 nays. YEAS: Rep. Dan Boren D-OK (2nd), Rep. Tom Cole R-OK (4th), Rep. Mary Fallin R-OK (5th), Rep. Frank D. Lucas R-OK (3rd) NAYS: Rep. John Sullivan R-OK (1st)

House Vote 5: SOUTHERN SEA OTTER POPULATION: The House approved the Southern Sea Otter Recovery and Research Act (H.R. 556), sponsored by Rep. Sam Farr, D-Calif., to have the Fish and Wildlife Service study faltering population growth in the southern sea otter species, which is found off the coast of central California, and to adopt measures to increase its population.

Proponents said the "keystone species" was necessary to sustain the world’s ecological system and the coastal and near-shore environment that affects the well-being of all people.

Opponents said the bill "will take a threatened species and place its management needs above others, even if those species are in danger of becoming extinct."

The vote, on July 28, was 316 yeas to 107 nays. YEAS: Rep. Dan Boren D-OK (2nd), Rep. Tom Cole R-OK (4th), Rep. Frank D. Lucas R-OK (3rd) NAYS: Rep. Mary Fallin R-OK (5th), Rep. John Sullivan R-OK (1st)

House Vote 6: PROTECTING MARINE TURTLES: The House approved the Marine Turtle Conservation Reauthorization Act (H.R. 509), sponsored by Rep. Henry Brown, R-S.C., to extend an existing program to sustain the health of various marine sea turtle species.

Proponents said that "the status of these turtle species remains tenuous" because of a variety of threats that would justify the need to reauthorize funding. The vote, on July 28, was 354 yeas to 72 nays. YEAS: Rep. Dan Boren D-OK (2nd), Rep. Tom Cole R-OK (4th), Rep. Mary Fallin R-OK (5th), Rep. Frank D. Lucas R-OK (3rd) NAYS: Rep. John Sullivan R-OK (1st)

House Vote 7: DOD APPROPRIATIONS: The House passed the Department of Defense Appropriations Act (H.R. 3326) sponsored by Rep. John Murtha, D-Pa., that set $636 billion in appropriations for the Defense Department for fiscal 2010 to provide funding for military aircraft acquisition, support to U.S. troops in war zones and provide medical care for troops and their families.

Proponents said "this Defense bill is all about taking care of the troops, making sure they have what they need." Opponents said: "We should be using this money to fund universal health care for, or to reform our educational system and train and prepare the next generation to run the green economy of the future, or to reorder our foreign policy around a smart security strategy that emphasizes development and diplomacy." The vote, on July 30, was 400 yeas to 30 nays. YEAS: Rep. Dan Boren D-OK (2nd), Rep. Tom Cole R-OK (4th), Rep. Mary Fallin R-OK (5th), Rep. Frank D. Lucas R-OK (3rd), Rep. John Sullivan R-OK (1st)

House Vote 8: LIBRARY OF CONGRESS FUNDING: The House passed the William Orton Library Improvement and Modernization Act (H.R. 2728) sponsored by Rep. Zoe Lofgren, D-Calif., to provide financial support for the operation of the law library of the Library of Congress and to authorize $3.5 million for maintaining and administering the operations of the Law Library, including the cataloging of the collections and for the creation of the William Orton Program to provide expanded services and programs at the library.

Proponents said "This bill will help ensure that the Law Library will have the resources needed to maintain and expand its collections while at the same time modernizing its systems." The vote, on July 30, was 383 yeas to 44 nays. YEAS: Rep. Dan Boren D-OK (2nd), Rep. Tom Cole R-OK (4th), Rep. Mary Fallin R-OK (5th), Rep. Frank D. Lucas R-OK (3rd), Rep. John Sullivan R-OK (1st) House Vote 9: FOOD SAFETY ENHANCEMENT: The House passed the Food Safety Enhancement Act (H.R. 2749) sponsored by Rep. John Dingell, D-Mich., that will amend the Federal Food, Drug and Cosmetic Act to improve global food safety efforts.

Proponents said the legislation would install a responsible program for control by requiring the registration of producers and manufacturers so the FDA can track food manufacturing processes for food produced outside and inside the U.S. Opponents called the legislation "woefully inadequate" and said it failed to achieve a truly improved food safety system because it would expand the reach and authority of the FDA but would not require further accountability or spending any additional funds on the inspection of food.

The vote, on July 30, was 283 yeas to 142 nays. YEAS: Rep. Dan Boren D-OK (2nd) NAYS: Rep. Tom Cole R-OK (4th), Rep. Mary Fallin R-OK (5th), Rep. Frank D. Lucas R-OK (3rd), Rep. John Sullivan R-OK (1st)

SENATE VOTES: Senate Vote 1: NO-BID CONTRACTS AT ENERGY, WATER

AGENCIES: The Senate rejected an amendment sponsored by Sen. Tom Coburn, R-Okla., to the Energy and Water Appropriations Act (H.R. 3183) that would have barred no bid contracts being awarded under the bill.

Proponents said the amendment would prevent billions of dollars of contracts from being "placed directly to businesses in this country at higher rates than they would have been otherwise had we had competitive bidding and open contracting."

Opponents said many of the contracts involved "very high-tech, exotic research we are doing in a wide range of energy fields" and were too specialized to be put out for competitive bidding. The vote, on July 29, was 26 yeas to 71 nays. YEAS: Sen. Tom Coburn R-OK, Sen. James M. Inhofe R-OK

Senate Vote 2: ENERGY AND WATER APPROPRIATIONS:

The Senate approved the Energy and Water Appropriations Act (H.R. 3183), sponsored by Rep. Ed Pastor, D-Ariz., to fund energy and water agencies in fiscal 2010.

Proponents said "this bill provides funding to address critical issues that affect our Nation’s security and prosperity [and] represents the fair and balanced treatment of competing priorities," preserving funds for high-priority programs and cutting funds for low-priority programs.

Opponents objected to the authorization of no-bid earmarked projects and said it denied the "transparency the American people are aching for in this area of earmarking."

The vote, on July 29, was 85 yeas to 9 nays. NAYS: Sen. Tom Coburn R-OK, Sen. James M. Inhofe R-OK

Senate Vote 3: HIGHWAY TRUST FUND: The Senate passed the Highway Trust Fund Act (H.R. 3357) sponsored by Rep. Charles Rangel, D-N.Y., that will provide $7 billion in funding to the Highway Trust Fund.

Proponents said the bipartisan bill "will provide the necessary funds to keep important transportation projects operating in states around the country."

Concerns were raised that the legislation would only be a short-term solution to an immediate crisis that should to be solved through long-term reforms so that third bailout of the Highway Trust Fund doesn’t become necessary.

The vote, on July 30, was 79 yeas to 17 nays. NAYS: Sen. Tom Coburn R-OK NOT VOTING: Sen. James M. Inhofe R-OK

 

Bill introduced to repeal Real ID Act

NEW YORK, July 31 — The American Civil Liberties Union issued the following news release:

In a welcome move today, legislation was introduced in the House of Representatives to repeal the discredited Real ID Act of 2005.

The REAL ID Repeal and Identification Security Enhancement Act of 2009, introduced by Representative Steve Cohen (D-TN), would repeal Real ID and replace it with the original negotiated rulemaking process passed by Congress as part of the 9/11 Commission recommendations.

Twenty-five states have already rejected Real ID, citing its high cost, invasiveness and the bureaucratic hassles it creates for citizens.
"Real ID is essentially dead. It’s time for it to be formally repealed and replaced with a process that works, one that protects civil liberties and license security," said Michael Macleod-Ball, Acting Director of the ACLU Washington Legislative Office. "Rep. Cohen took a big step forward by moving to eliminate this failed law and providing much-needed safeguards for our civil liberties."

The Real ID Act of 2005 directs states to issue a federally-approved driver’s license or other form of ID that would be necessary for airline travel and become part of a national database. Like state governments from coast to coast, the American Civil Liberties Union has long opposed the Act as too invasive, too much red tape and too expensive.

Fifteen states have passed binding legislation prohibiting participation in the Real ID program: Alaska, Arizona, Georgia, Idaho, Louisiana, Maine, Minnesota, Montana, New Hampshire, Oklahoma, South Carolina, Virginia, Washington, Oregon, and Missouri.

Ten other states have enacted resolutions in opposition to Real ID: Arkansas, Colorado, Hawaii, Illinois, Missouri, Nebraska, Nevada, North Dakota, South Dakota and Tennessee.

Similar to the Akaka-Sununu Senate bill of 2007 and the Allen House bill of 2007, Rep. Cohen’s bill would eliminate most of the requirements that laid the foundation for a National ID card, such as the obligation that all data and systems be standardized.

The proposal also requires a collaborative approach, called negotiated rulemaking, which would advise the Department of Homeland Security on how to maximize driver’s license security while minimizing the administrative burden on the states.

This approach was initially adopted by the law which implemented the 9/11 Commission recommendations and subsequently repealed by Real ID.

Significant privacy protections in the proposal include prohibiting the use of license data by third parties, encryption of the data and adherence to state privacy laws that may provide greater protection.

Additionally, Rep. Cohen’s bill would also provide for the establishment of a negotiated rulemaking committee, which would present its recommendations to the Department of Homeland Security.

"States and ordinary Americans have all rejected a National ID card," said Christopher Calabrese, Counsel for the ACLU Technology and Liberty Project. "Now it’s time for Congress to follow their lead and finally get rid of the Real ID Act by passing Rep. Cohen’s bill."

To learn more about the Real ID Act or read about its history, visit www.realnightmare.org

 

Journey comes to Tulsa

Tulsa Today is pleased to welcome classic rock bands Journey and Night Ranger to the BOK Center this evening for what is sure to be a lively night of great rock and roll.

Journey, who has sold over 47 million records, not only “created the power ballad” (BOK Center), they are a band that has truly survived the test of time.

Tickets for this evening’s show range from $29.50-$79.50 and may be purchased at the BOK Center box office or online at www.bokcenter.com.

Doors are scheduled to open at 6:30p.m. and the show starts at 7:30p.m.  The BOK Center is requesting no audio, video or professional photography, please.
Journey’s new 10-week tour, which has been one of the most anticipated concerts of the year, is scheduled to end with a September 26 concert at New Orleans Arena in New Orleans, LA.

Just wrapping up a July 29-30 performance at Pala Casino in Pala, CA, the group arrives into Tulsa rested and ready to rock.

With this tour, Journey is promoting its 13th studio album, "Revelation," released in June 2008, which hit No. 5 on the Billboard 200 and peaked at No. 1 on the independent albums chart.

The Platinum-certified release is also the first to feature new lead singer Arnel Pineda, who is based in the Philippines.

“In early December 2007, Journey announced that the Manila-born vocalist would be the most recent replacement for original singer Steve Perry, who left the band after a hip injury suffered in 1997 prevented him from touring.

In the decade since Perry’s departure, several vocalists have filled in for him on the band’s tours and albums.” (Ticketnews.com)

For more information on this event, visit the BOK Center website at http://www.bokcenter.com/events.asp?id=11&pid=171&task=display

Hear some great utube recordings here: site one and site two.

Journey’s official website: http://www.journeymusic.com/home

 

Clinical trial seeking volunteers

Wednesday, 05 August 2009
REDMOND, Wash.– Oklahoma State University issued the following news release: Spiration, Inc., a developer of novel medical devices designed to benefit patients with acute and chronic conditions of the lung, announced today that several new clinical sites are now actively recruiting patients for participation in a pivotal trial of the company’s minimally invasive treatment for severe emphysema.

These sites include Oklahoma State University Center for Health Sciences, Tulsa, Okla., Akron General Medical Center in Akron, Ohio; Medical College of Wisconsin in Milwaukee, Wis.; National Jewish Health in Denver, Colo.; New York-Presbyterian Hospital/Columbia University Medical Center in New York, N.Y.; Southern Illinois University School of Medicine in Springfield, Ill.; University of Iowa Health Care in Iowa City, Iowa; University of California, San Diego Medical Center; the University of Chicago Medical Center; the University of Florida in Gainesville, Fla.; and the University of Washington Medical Center in Seattle, Wash.

"We’re very excited about the addition of these well-respected sites to the first-rate hospitals already participating in the IBV Valve Trial," said Rick Shea, president and CEO, Spiration.

"The approximately 30 sites actively enrolling patients in the study are leaders in their communities helping to advance medical research that may one day improve the lives of people with emphysema, a debilitating condition that severely impacts quality of life."

Other sites now actively recruiting patients for the study include:

Alexian Brothers Medical Center, Elk Grove Village, Ill.

Cleveland Clinic, Cleveland, Ohio

Emory Healthcare, Atlanta, Ga.

Franciscan Health System Research Center, Tacoma, Wash.

Franklin Square Hospital Center/Pulmonary & Critical Care Associates, Baltimore, Md.

HealthPartners, St. Paul, Minn.

Lehigh Valley Health Network, Allentown, Pa.

Mount Sinai Medical Center, New York, N.Y.

Oklahoma State University Center for Health Sciences, Tulsa, Okla.

Pulmonary Associates of Mobile, P.C., Mobile, Alabama

Rhode Island Hospital, Providence, R.I.

Ronald Reagan UCLA Medical Center, Los Angeles, Calif.

Sarasota Memorial Hospital, Sarasota, Fla.

Scott & White Memorial Hospital, Temple, Texas

University of Alabama at Birmingham, Ala.

University of California Davis Medical Center, Sacramento, Calif.

University of Louisville, Louisville, Ky.

University of Pennsylvania Health System, Philadelphia, Pa.

University of Utah, Salt Lake City, Utah

University of Texas Health Science Center at San Antonio, Texas

University of Virginia Health System, Charlottesville, Va.

About the IBV Valve Trial
The pivotal trial to treat patients with emphysema will generate safety and effectiveness data for submission to the U.S. Food and Drug Administration (FDA). This prospective, randomized, blinded clinical trial will enroll up to 500 patients at up to 50 sites in the United States.

Study investigators are still actively recruiting patients for the IBV Valve Trial. The study is open to men and women age 40 to 74 who have been diagnosed with predominantly upper lobe emphysema and shortness of breath with exertion.

Eligible patients must be able to participate in pulmonary function and standardized exercise tests, have not smoked for four months and be willing to not smoke during the trial. Additional criteria must be met for participation in the study. For more information, including a complete list of trial site locations, please visit www.emphysematrial.com or call 877-54-STUDY (877-547-8839).

About the IBV Valve System

The IBV Valve System is a minimally invasive treatment that has diverse applications in both acute and chronic conditions of the lung. During the minimally invasive procedure, a catheter is passed through a bronchoscope (a flexible tube passed into the bronchial tubes through the mouth or nose) to deploy the small umbrella-shaped valves into the airways of the lungs. The valves are designed to be easily removed via a similar bronchoscopic procedure.

The device has received Humanitarian Device Exemption (HDE) approval from the U.S. Food and Drug Administration (FDA) to control prolonged air leaks of the lung, or significant air leaks that are likely to become prolonged, following lobectomy, segmentectomy, or lung volume reduction surgery. The effectiveness of this device for this use has not been demonstrated.

The IBV Valve System is currently under investigation in the U.S. as a new treatment option for the many people with severe emphysema who do not respond well to current medical therapies or are not eligible for or elect not to undergo invasive surgery such as lung volume reduction or lung transplantation.

The IBV Valve System is marketed and distributed by Olympus in Europe, where the system has received market clearance through the CE Mark for the treatment of diseased and damaged lung, an indication that includes the treatment of emphysema and the control of prolonged air leaks. Olympus also has development and distribution rights for the IBV Valve System in Japan.

About Spiration, Inc.
Spiration, Inc. is committed to improving quality of life for patients with acute and chronic conditions of the lung through the development of novel therapies. Founded in 1999 in Redmond, Wash., the privately held company is backed by prominent investors including Three Arch Partners, New Enterprise Associates, Versant Ventures, New Leaf Ventures (Sprout Group), InterWest Partners, Investor Growth Capital, Saints Capital and Olympus Medical Systems Corp. For more information, visit the company’s website at www.spiration.com.

Information about the U.S. pivotal study of Spiration’s IBV Valve System may be found at www.emphysematrial.com.

Caution: The IBV Valve is not yet approved for use in emphysema, but is subject to an ongoing clinical investigation in which approval for use in emphysema will be sought. The IBV Valve is a Humanitarian Use Device authorized by Federal (or United States) Law for the control of prolonged air leaks of the lung, or significant air leaks that are likely to become prolonged following lobectomy, segmentectomy, or lung volume reduction surgery. The effectiveness of this device for this use has not been demonstrated.

Photo credits: general stock photo on web

Last Updated ( Wednesday, 05 August 2009 )

Freedmen Association hosts meeting Saturday

Wednesday, 05 August 2009
The Descendants of Freedmen Association will host their next meeting on Sat., Aug. 8, 2009 in Muskogee Oklahoma.

The meeting will be held beginning at 1pm at Elliot Park.  Attendants are asked to bring a "covered dish" to share with other meeting attendants. Meeting attendants will be updated about the recent naacp national conference.

For more information on the meeting, please contact Mister Graham: 918-756-5886 or Mrs Vann: 405-818-5360.  Immediately following the Descendants meeting will be a meeting of the Cherokee freeedmen band of OKlahoma.

Meeting attendants will be updated on recent events in Washington DC as well as federal case updates.

For more information on the meeting, please contact Mrs Vann: 405-818-5360 or Mister Hightower: 918-360-2029

Both meetings are free and open to the general public of all races, creeds, colors and tribal affiliations.

Last Updated ( Wednesday, 05 August 2009 )